Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lilach, Moyal"'
Autor:
Avishai Maliah, Nadine Santana-Magal, Shivang Parikh, Sagi Gordon, Keren Reshef, Yuval Sade, Aseel Khateeb, Alon Richter, Amit Gutwillig, Roma Parikh, Tamar Golan, Matan Krissi, Manho Na, Gal Binshtok, Paulee Manich, Nadav Elkoshi, Sharon Grisaru-Tal, Valentina Zemser-Werner, Ronen Brenner, Hananya Vaknine, Eran Nizri, Lilach Moyal, Iris Amitay-Laish, Luiza Rosemberg, Ariel Munitz, Noga Kronfeld-Schor, Eric Shifrut, Oren Kobiler, Asaf Madi, Tamar Geiger, Yaron Carmi, Carmit Levy
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract T cell inhibitory mechanisms prevent autoimmune reactions, while cancer immunotherapy aims to remove these inhibitory signals. Chronic ultraviolet (UV) exposure attenuates autoimmunity through promotion of poorly understood immune-suppressiv
Externí odkaz:
https://doaj.org/article/558f6188a6ba4158b35fee08d311324d
Autor:
Asher Hackett, Avi Adam Cohen, Tal Frenkel Rutenberg, Emmilia Hodak, Lilach Moyal, Lihi Atzmony
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/6aa5251fb12e48f49d196af20d8202aa
Autor:
Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Daniel Schmolze, Chingyu Su, Jasmine Zain, Lilach Moyal, Emmilia Hodak, James F. Sanchez, Peter P. Lee, Mingye Feng, Steven T. Rosen, Christiane Querfeld
Publikováno v:
JCI Insight, Vol 8, Iss 13 (2023)
Cutaneous T cell lymphoma (CTCL) is a disfiguring and incurable disease characterized by skin-homing malignant T cells surrounded by immune cells that promote CTCL growth through an immunosuppressive tumor microenvironment (TME). Preliminary data fro
Externí odkaz:
https://doaj.org/article/aea90ab340bd4aec9702c4b9ba05a095
Autor:
Lihi Atzmony, Lilach Moyal, Meora Feinmesser, Batya Gorovitz, Avraham Hirshberg, Iris Amitay-Laish, Hadas Prag-Naveh, Aviv Barzilai, Emmilia Hodak
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 15, p adv00230 (2020)
Recent studies suggest that folliculotropic mycosis fungoides (FMF), the most common variant of mycosis fungoides (MF), presents with 2 distinct clinicopathological stages: early indolent stage and more aggressive advanced/tumour stage. To further ch
Externí odkaz:
https://doaj.org/article/568373d9ad6c47929a606b4dbb153a29
Autor:
Rony Shreberk-Hassidim, Anat Geiger-Maor, Galit Eisenberg, Sharon Merims, Emma Hajaj, Jonathan E. Cohen, Shiri Klein, Shoshana Frankenburg, Lilach Moyal, Emilia Hodak, Abraham Zlotogorski, Michal Lotem
Publikováno v:
Immunologic Research. 70:793-799
Immune checkpoint receptors (ICR) modulate the immune response and are critical hubs for immunotherapy. However, data on their role in T lymphoid malignancies, such as cutaneous T cell lymphoma (CTCL), is sparse. We aimed to explore the role of ICR i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25b34eceabc8d0307ee2ed7e7bcdca46
https://doi.org/10.1007/s12026-022-09308-6
https://doi.org/10.1007/s12026-022-09308-6
Autor:
Lilach Moyal, Nataly Feldbaum, Neta Goldfeiz, Ada Rephaeli, Abraham Nudelman, Michal Weitman, Nataly Tarasenko, Batia Gorovitz, Leah Maron, Shiran Yehezkel, Iris Amitay-Laish, Ido Lubin, Emmilia Hodak
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146115 (2016)
The 2 histone deacetylase inhibitors (HDACIs) approved for the treatment of cutaneous T-cell lymphoma (CTCL) including mycosis fungoides/sezary syndrome (MF/SS), suberoylanilide hydroxamic acid (SAHA) and romidepsin, are associated with low rates of
Externí odkaz:
https://doaj.org/article/9ab3cb25672a40d497fe1695f1a53697
Autor:
Amir Tiroler, Dvora Namdar, Guy Drori, Hinanit Koltai, Lilach Moyal, Stalin Nadarajan, Emmilia Hodak, Iris Amitay-Laish, Adi Faigenboim, Moran Mazuz, Owen Van Cauwenberghe, Avi Drori, Ajjampura C. Vinayaka, Ido Lubin, Batia Gorovitz-Haris
Publikováno v:
Oncotarget. 11:1141-1156
Cannabis sativa produces hundreds of phytocannabinoids and terpenes. Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL), characterized by patches, plaques and tumors. Sezary is a leukemic stage of CTCL presenting with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9483e89a34a19dfd71d76402f4c9e7bc
https://doi.org/10.18632/oncotarget.27528
https://doi.org/10.18632/oncotarget.27528
Autor:
Lilach Moyal, Lihi Atzmony, Emmilia Hodak, Avraham Hirshberg, Aviv Barzilai, Batya Gorovitz, Iris Amitay-Laish, Meora Feinmesser, Hadas Prag-Naveh
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 15, p adv00230 (2020)
Recent studies suggest that folliculotropic mycosis fungoides (FMF), the most common variant of mycosis fungoides (MF), presents with 2 distinct clinicopathological stages: early indolent stage and more aggressive advanced/tumour stage. To further ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e917ffa86719c15dd9e0fac79a845c
https://doaj.org/article/568373d9ad6c47929a606b4dbb153a29
https://doaj.org/article/568373d9ad6c47929a606b4dbb153a29
Autor:
Hadas Prag Naveh, Dafna Shilo Yaacobi, Iris Amitay-Laish, Jamal Knaneh, Anna Aronovich, Lea Maron, Eric Barel, Emmilia Hodak, Neta Erez, Lilach Moyal, Batia Gorovitz, Yaara Forer, Dean Ad-El
Publikováno v:
The Journal of investigative dermatology. 141(3)
Cancer cells are known to reprogram normal fibroblasts into cancer-associated fibroblasts (CAFs) to act as tumor supporters. The presence and role of CAFs in mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, are unknown. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::394c761872dc886f626643469195e294
https://pubmed.ncbi.nlm.nih.gov/33618804
https://pubmed.ncbi.nlm.nih.gov/33618804
Autor:
Lilach Moyal, Emmilia Hodak, Jamal Knaneh, Khaneen Houry, Anna Aronovich, Batia Gorovitz, Lea Maron
Publikováno v:
European Journal of Cancer. 156:S12
The C-X-C chemokine receptor 4 (CXCR4) is overexpressed in the tumor cells of many solid and hematologic neoplasms. Its ligand, C-X-C chemokine ligand 12 (CXCL12), is secreted by cells in the tumor microenvironment, mostly by stromal fibroblasts. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68dd152868a8ceda18b45faafa46858d
https://doi.org/10.1016/s0959-8049(21)00648-1
https://doi.org/10.1016/s0959-8049(21)00648-1